OYST - Oyster Point Pharma Inc
Close
11.17
0.020 0.179%
Share volume: 0
Last Updated: Fri 30 Dec 2022 10:00:01 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.15
0.02
0.18%
Summary score
21%
Profitability
25%
Dept financing
1%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.62%
Return on assets
-12.12%
Return on sales
0%
Return on invested capital
334.65%
Total debt ratio
5.91%
Debt ratio change over timeo
-0.98%
Current Ratio
19.96%
Quick Ratio
0%
Cash Position Ratio
19.5%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.62%
Return on assets
-12.12%
Return on sales
0%
Return on invested capital
334.65%
Total debt ratio
5.91%
Debt ratio change over timeo
-0.98%
Current Ratio
19.96%
Quick Ratio
0%
Cash Position Ratio
19.5%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7%
Return on assets
-6.74%
Return on sales
0%
Return on invested capital
212.8%
Total debt ratio
3.99%
Debt ratio change over time
-0.98%
Current Ratio
26.32%
Quick Ratio
0%
Cash Position Ratio
26.11%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-103.2%
Return on assets
-103.08%
Return on sales
0%
Return on invested capital
-17.84%
Total debt ratio
-98.45%
Debt ratio change over time
-0.98%
Current Ratio
6.32%
Quick Ratio
0%
Cash Position Ratio
6.23%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OYST | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.62% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.12% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 334.65% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 59% |
| Total debt ratio | 5.91% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.98% | 6.09% | 6.03% | 1.53% |
| Dept financing | 1% | 50% | 43% | 14% |
| Current Ratio | 19.96% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 19.5% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 13% | 30% | 29% |
| Short-term ratios | OYST | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.62% | -25.62% | 17.94% | 7.14% |
| Return on assets | -12.12% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 334.65% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 5.91% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.98% | -23.44% | 9.66% | 0.6% |
| Dept financing | 1% | 25% | 45% | 8% |
| Current Ratio | 19.96% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 19.5% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 22% | 18% | 31% |